Chrysophanol: A promising natural compound in cancer therapy – Mechanistic insights and future perspectives

IF 9.1 2区 医学 Q1 PHARMACOLOGY & PHARMACY Pharmacological research Pub Date : 2024-11-07 DOI:10.1016/j.phrs.2024.107502
Dehong Liu , Kun Zhu , Tao Guo , Yao Xiao , Meijing Wang , Yanxin Guan , Junjun Li , Degui Chang , Xujun Yu
{"title":"Chrysophanol: A promising natural compound in cancer therapy – Mechanistic insights and future perspectives","authors":"Dehong Liu ,&nbsp;Kun Zhu ,&nbsp;Tao Guo ,&nbsp;Yao Xiao ,&nbsp;Meijing Wang ,&nbsp;Yanxin Guan ,&nbsp;Junjun Li ,&nbsp;Degui Chang ,&nbsp;Xujun Yu","doi":"10.1016/j.phrs.2024.107502","DOIUrl":null,"url":null,"abstract":"<div><div>Cancer continues to be a leading cause of death worldwide, highlighting the urgent need for the development of new therapeutic strategies. Chrysophanol, a naturally occurring anthraquinone compound, has demonstrated significant potential in cancer treatment due to its diverse biological activities. This review delves into the mechanisms through which chrysophanol exerts its anti-cancer effects, including the induction of cell cycle arrest, promotion of apoptosis, regulation of autophagy, and initiation of necrosis across various cancer cell lines. Additionally, the review discusses chrysophanol's impact on inhibiting cancer cell invasion and metastasis and its role in modulating chemotherapy sensitivity. Despite the promising therapeutic potential of chrysophanol, challenges such as poor water solubility, low bioavailability, and safety concerns remain. Comprehensive clinical trials are essential to validate its efficacy and safety. This review emphasizes chrysophanol as a promising candidate for cancer therapy and underscores the necessity for further research to fully harness its therapeutic potential.</div></div>","PeriodicalId":19918,"journal":{"name":"Pharmacological research","volume":"210 ","pages":"Article 107502"},"PeriodicalIF":9.1000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S104366182400447X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Cancer continues to be a leading cause of death worldwide, highlighting the urgent need for the development of new therapeutic strategies. Chrysophanol, a naturally occurring anthraquinone compound, has demonstrated significant potential in cancer treatment due to its diverse biological activities. This review delves into the mechanisms through which chrysophanol exerts its anti-cancer effects, including the induction of cell cycle arrest, promotion of apoptosis, regulation of autophagy, and initiation of necrosis across various cancer cell lines. Additionally, the review discusses chrysophanol's impact on inhibiting cancer cell invasion and metastasis and its role in modulating chemotherapy sensitivity. Despite the promising therapeutic potential of chrysophanol, challenges such as poor water solubility, low bioavailability, and safety concerns remain. Comprehensive clinical trials are essential to validate its efficacy and safety. This review emphasizes chrysophanol as a promising candidate for cancer therapy and underscores the necessity for further research to fully harness its therapeutic potential.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Chrysophanol:一种在癌症治疗中大有可为的天然化合物--机理认识与未来展望。
癌症仍然是导致全球死亡的主要原因,因此迫切需要开发新的治疗策略。蛹虫草酚是一种天然的蒽醌化合物,由于其具有多种生物活性,在癌症治疗方面已显示出巨大的潜力。本综述深入探讨了金丝桃醇发挥其抗癌作用的机制,包括诱导细胞周期停滞、促进细胞凋亡、调节自噬和引发各种癌细胞株的坏死。此外,综述还讨论了菊醇对抑制癌细胞侵袭和转移的影响,以及它在调节化疗敏感性方面的作用。尽管菊醇具有良好的治疗潜力,但仍存在水溶性差、生物利用率低和安全性问题等挑战。全面的临床试验对于验证其疗效和安全性至关重要。这篇综述强调了菊醇是一种很有希望的癌症治疗候选药物,并强调了进一步研究以充分利用其治疗潜力的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pharmacological research
Pharmacological research 医学-药学
CiteScore
18.70
自引率
3.20%
发文量
491
审稿时长
8 days
期刊介绍: Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. Pharmacological research publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.
期刊最新文献
Comparative effectiveness and safety of imported and domestic immune checkpoint inhibitors in China: A systematic review and pairwise and network meta-analyses Corrigendum to "Overcoming limitations and advancing the therapeutic potential of antibody-oligonucleotide conjugates (AOCs): Current status and future perspectives" [Pharmacol. Res. 209 (2024) 107469]. Effect of anthocyanins on metabolic syndrome through interacting with gut microbiota PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy Role for the F-box proteins in heart diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1